Hartung T - Search Results

1

Diagnosis: toxic!--trying to apply approaches of clinical diagnostics and prevalence in toxicology considerations.

Hoffmann S, Hartung T. Hoffmann S, et al. Among authors: hartung t. Toxicol Sci. 2005 May;85(1):422-8. doi: 10.1093/toxsci/kfi099. Epub 2005 Feb 2. Toxicol Sci. 2005. PMID: 15689419

2

Comments on the use of bootstrap resampling to assess the uncertainty of Cooper statistics.

Hoffmann S, Hartung T, Beran J. Hoffmann S, et al. Among authors: hartung t. Altern Lab Anim. 2002 Sep-Oct;30(5):551-4; author reply 555-7. doi: 10.1177/026119290203000508. Altern Lab Anim. 2002. PMID: 12405882 No abstract available.

3

Evaluation and prevalidation of an immunotoxicity test based on human whole-blood cytokine release.

Langezaal I, Hoffmann S, Hartung T, Coecke S. Langezaal I, et al. Among authors: hartung t. Altern Lab Anim. 2002 Nov-Dec;30(6):581-95. doi: 10.1177/026119290203000605. Altern Lab Anim. 2002. PMID: 12513684

4

Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood.

von Aulock S, Schröder NW, Gueinzius K, Traub S, Hoffmann S, Graf K, Dimmeler S, Hartung T, Schumann RR, Hermann C. von Aulock S, et al. Among authors: hartung t. J Infect Dis. 2003 Sep 15;188(6):938-43. doi: 10.1086/378095. Epub 2003 Aug 28. J Infect Dis. 2003. PMID: 12964127

5

A modular approach to the ECVAM principles on test validity.

Hartung T, Bremer S, Casati S, Coecke S, Corvi R, Fortaner S, Gribaldo L, Halder M, Hoffmann S, Roi AJ, Prieto P, Sabbioni E, Scott L, Worth A, Zuang V. Hartung T, et al. Altern Lab Anim. 2004 Nov;32(5):467-72. doi: 10.1177/026119290403200503. Altern Lab Anim. 2004. PMID: 15656771

6

Skin irritation: prevalence, variability, and regulatory classification of existing in vivo data from industrial chemicals.

Hoffmann S, Cole T, Hartung T. Hoffmann S, et al. Among authors: hartung t. Regul Toxicol Pharmacol. 2005 Apr;41(3):159-66. doi: 10.1016/j.yrtph.2004.11.003. Epub 2005 Jan 20. Regul Toxicol Pharmacol. 2005. PMID: 15748793

7

Optimisation of pyrogen testing in parenterals according to different pharmacopoeias by probabilistic modelling.

Hoffmann S, Luderitz-Puchel U, Montag T, Hartung T. Hoffmann S, et al. Among authors: hartung t. J Endotoxin Res. 2005;11(1):25-31. doi: 10.1179/096805105225006678. J Endotoxin Res. 2005. PMID: 15826375

8

International validation of novel pyrogen tests based on human monocytoid cells.

Hoffmann S, Peterbauer A, Schindler S, Fennrich S, Poole S, Mistry Y, Montag-Lessing T, Spreitzer I, Löschner B, van Aalderen M, Bos R, Gommer M, Nibbeling R, Werner-Felmayer G, Loitzl P, Jungi T, Brcic M, Brügger P, Frey E, Bowe G, Casado J, Coecke S, de Lange J, Mogster B, Naess LM, Aaberge IS, Wendel A, Hartung T. Hoffmann S, et al. Among authors: hartung t. J Immunol Methods. 2005 Mar;298(1-2):161-73. doi: 10.1016/j.jim.2005.01.010. J Immunol Methods. 2005. PMID: 15847806

9

Designing validation studies more efficiently according to the modular approach: retrospective analysis of the EPISKIN test for skin corrosion.

Hoffmann S, Hartung T. Hoffmann S, et al. Among authors: hartung t. Altern Lab Anim. 2006 May;34(2):177-91. doi: 10.1177/026119290603400209. Altern Lab Anim. 2006. PMID: 16704291

10

International validation of pyrogen tests based on cryopreserved human primary blood cells.

Schindler S, Spreitzer I, Löschner B, Hoffmann S, Hennes K, Halder M, Brügger P, Frey E, Hartung T, Montag T. Schindler S, et al. Among authors: hartung t. J Immunol Methods. 2006 Oct 20;316(1-2):42-51. doi: 10.1016/j.jim.2006.07.023. Epub 2006 Sep 7. J Immunol Methods. 2006. PMID: 16996078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

659 results

Search Page

Filters